Aalto computer scientists in AIES 2024
The AAAI/ACM Conference on AI, Ethics and Society is focusing on a ethical or societal issues of AI technology and crosscuts in these fields.
The conference is organised on 21-23 October 2024 in San Jose, California.
Accepted papers
Click the title to see the authors and the abstract. Link to the paper open on different website.
Authors
Vili Lehdonvirta (Aalto University), Boxi Wu, Zoe Hawkins
Abstract
Governments have begun to view AI compute infrastructures, including advanced AI chips, as a geostrategic resource. This is partly because “compute governance” is believed to be emerging as an important tool for governing AI systems. In this governance model, states that host AI compute capacity within their territorial jurisdictions are likely to be better placed to impose their rules on AI systems than states that do not. In this study, we provide the first attempt at mapping the global geography of public cloud GPU compute, one particularly important category of AI compute infrastructure. Using a census of hyperscale cloud providers’ cloud regions, we observe that the world is divided into “Compute North” countries that host AI compute relevant for AI development (ie. training), “Compute South” countries whose AI compute is more relevant for AI deployment (ie. running inferencing), and “Compute Desert” countries that host no public cloud AI compute at all. We generate potential explanations for the results using expert interviews, dis-cuss the implications to AI governance and technology geopolitics, and consider possible future trajectories.
Read more news
ACRIS service restored
The ACRIS research information management system is now open following the planned service break on 13–20 April 2026.
Science must have a voice in society – but how?
Trust in science has fallen in Finland by almost ten percentage points in two years
Meet our startup: Proteins.1 aims for a breakthrough in early disease detection
Biotechnology startup Proteins.1 is developing a technology that could enable the detection of diseases such as cancer months, or even years, earlier than is currently possible. The key lies in identifying individual proteins from a blood sample.